Vertraagde tijd
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
13,85 CAD | +1,61% | +2,59% | +0,73% |
Vakgebied
Verkoop per activiteit
CAD in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
Investment and Related Activities
100,0
%
| 4 | 100,0 % | 3 | 100,0 % | -20,03% |
Verkoop per regio
CAD in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
Canada
100,0
%
| 4 | 100,0 % | 3 | 100,0 % | -20,03% |
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Michael Kovacs
CEO | Chief Executive Officer | - | - |
Daniel Lazzer
DFI | Director of Finance/CFO | - | - |
Mary Medeiros
COO | Chief Operating Officer | - | - |
David Balsdon
CMP | Compliance Officer | - | - |
Chief Investment Officer | - | - |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Michael Kovacs
CEO | Chief Executive Officer | - | - |
Mary Medeiros
COO | Chief Operating Officer | - | - |
Nicholas Bontis
BRD | Director/Board Member | - | - |
Bedrijfsgegevens
Big Pharma Split Corp.
610 Chartwell Road Suite 204
L6J 4A5, Oakville
+416-649-4541
http://www.harvestportfolios.com/closed-end-funds/big-pharma-split-corp/Sector
Vaira. 1 jan. | Kapi. | |
---|---|---|
+0,73% | 11,76 mln. | |
+3,26% | 229 mln. | |
+24,72% | 206 mln. | |
+16,60% | 186 mln. | |
+9,14% | 111 mln. | |
-0,32% | 82,73 mln. | |
-14,61% | 50,95 mln. |